Abstract

Infants may develop severe viral respiratory tract infections because their immune system is still developing in the first months after birth. Human milk provides passive humoral immunity during the first months of life. During the COVID-19 pandemic, circulation of common respiratory viruses was virtually absent due to the preventative measures resulting in reduced maternal exposure. Therefore, we hypothesized that this might result in lower antibody levels in human milk during the pandemic and, subsequently, decreased protection of infants against viral respiratory tract infections. We assessed antibody levels against respiratory syncytial virus (RSV), Influenza virus, and several seasonal coronaviruses in different periods of the COVID-19 pandemic in serum and human milk using a Luminex assay. IgG levels against RSV, Influenza, HCoV-OC43, HCoVHKU1, and HCoV-NL63 in human milk were reduced with a factor of 1.7 (P, 0.001), 2.2 (P, 0.01), 2.6 (P, 0.05), 1.4 (P, 0.01), and 2.1 (P, 0.001), respectively, since the introduction of the COVID-19 restrictions. Furthermore, we observed that human milk of mothers that experienced COVID-19 contained increased levels of IgG and IgA binding to other respiratory viruses. Passive immunity via human milk against common respiratory viruses was reduced during the COVID-19 pandemic, which may have consequences for the protection of breastfed infants against respiratory infections.

Original languageEnglish
Pages (from-to)e0040522
JournalMicrobiology spectrum
Volume10
Issue number4
DOIs
Publication statusPublished - 31 Aug 2022

Keywords

  • COVID-19
  • Influenza
  • RSV
  • antibodies
  • breast milk
  • coronaviruses

Cite this